0000950170-24-092719.txt : 20240807 0000950170-24-092719.hdr.sgml : 20240807 20240807160103 ACCESSION NUMBER: 0000950170-24-092719 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240805 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Murphy Keith CENTRAL INDEX KEY: 0001536583 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35996 FILM NUMBER: 241183448 MAIL ADDRESS: STREET 1: 6275 NANCY RIDGE DRIVE, SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ORGANOVO HOLDINGS, INC. CENTRAL INDEX KEY: 0001497253 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271488943 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-224-1000 MAIL ADDRESS: STREET 1: 11555 SORRENTO VALLEY ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: REAL ESTATE RESTORATION & RENTAL, INC. DATE OF NAME CHANGE: 20100722 4 1 ownership.xml 4 X0508 4 2024-08-05 0001497253 ORGANOVO HOLDINGS, INC. ONVO 0001536583 Murphy Keith 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 true true false false EXECUTIVE CHAIRMAN false Common Stock 2024-08-07 4 A false 19607 0 A 132641 D Options (right to buy) 0.5368 2024-08-05 4 A false 574923 0 A 2034-08-05 Common Stock 574923 574923 D Options (right to buy) 0.5368 2024-08-05 4 A false 143731 0 A 2034-08-05 Common Stock 143731 143731 D The reported securities are represented by restricted stock units, which shall vest on the earlier of August 7, 2025 or the date of the annual meeting of stockholders held by the Issuer in 2025, subject to acceleration in the event of a change of control. The option vests in 3 equal annual installments on each of August 5, 2025, August 5, 2026 and August 5, 2027. The option becomes exercisable if, after the grant date, the closing sales price of the Common Stock, as reported on the Nasdaq Capital Market (based on a 90-trading day average), is at least $1.53 (subject to adjustment for stock splits), as confirmed by the Board of Directors or a committee thereof. /s/ Keith Murphy 2024-08-07